A 76-year-old man with non-valvular atrial fibrillation attends for review. He has hypertension, type 2 diabetes and a prior ischaemic stroke 3 years ago with full recovery. He is currently taking aspirin 100 mg daily. According to stroke prevention recommendations, what is the most appropriate change to his antithrombotic therapy?